Concepedia

Ulf Jungnelius

UJ

Statistics

Publications

14

Citations

773

H-Index

13

Active since

1990

Affiliations

Sophiahemmet Hospital(Current)

Carlo Forlanini Hospital

Centrum Onkologii

Karolinska University Hospital

Comprehensive Cancer Centers of Nevada

Ulf Jungnelius is an author at Sophiahemmet Hospital specializing in oncology, medicine, and chemotherapy.

Publications per year

1990–2016

14

Publications

14

High‐Dose cisplatin treatment: Hearing loss and plasma concentrations

Göran Laurell, Ulf Jungnelius · The Laryngoscope · 1990 · 150 citations

, , +15

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial

Daniel P. Petrylak, Nicholas J. Vogelzang, Nikolay Budnik et al. · The Lancet Oncology · 2015 · 149 citations

, , +16

Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.

Johan Hansson, Kiflu Berhane, Víctor M. Castro et al. · PubMed · 1991 · 119 citations

, , +12

Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

Nicholas J. Vogelzang, Karim Fizazi, John M. Burke et al. · European Urology · 2016 · 64 citations

, , +16

Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial

Ulf Jungnelius, Ulrik Ringborg, S. Aamdal et al. · European Journal of Cancer · 1998 · 61 citations

, , +11

1–5 of 14